Intrinsic Value of S&P & Nasdaq Contact Us

Atreca, Inc. BCEL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+4344.4%

Atreca, Inc. (BCEL) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 4 Buy, 4 Hold.

The consensus price target is $4.00, representing an upside of 4344.4% from the current price $0.09.

BCEL Stock — 12-Month Price Forecast

$4.00
▲ +4,344.44% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Atreca, Inc., the price target is $4.00.
The average price target represents a +4,344.44% change from the last price of $0.09.

BCEL Analyst Ratings

Buy
8
Ratings
4 Buy
4 Hold
Based on 8 analysts giving stock ratings to Atreca, Inc. in the past 3 months
Rating breakdown
Buy
4 50%
Hold
4 50%
50%
Buy
4 analysts
50%
Hold
4 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message